{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:31:19Z","timestamp":1783949479473,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.ejca.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T14:06:18Z","timestamp":1466258778000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial"],"prefix":"10.1016","volume":"64","author":[{"given":"James A.","family":"Bonner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Harari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Baselga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeltje","family":"Schulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian K.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2016.05.008_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2016.05.008_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2016.05.008_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hed.21700","article-title":"Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer: a randomized study","volume":"34","author":"Silander","year":"2012","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.ejca.2016.05.008_bib4","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijrobp.2009.09.036","article-title":"Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer","volume":"78","author":"Chen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2016.05.008_bib5","first-page":"5s","article-title":"Impact of p16 status on the results of the phase III cetuximab (cet)\/radiotherapy (RT)","author":"Rosenthal","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2016.05.008_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2016.05.008_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2016.05.008_bib8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.ejca.2016.05.008_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1200\/JCO.2011.38.4099","article-title":"Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer","volume":"30","author":"Gillison","year":"2012","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2016.05.008_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2010.11.009","article-title":"Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer (LAHNSCC)","volume":"98","author":"Walsh","year":"2011","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2016.05.008_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jjco\/hyu196","article-title":"Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer","volume":"45","author":"Yokota","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2016.05.008_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3109\/00016489.2015.1030772","article-title":"Comparison of acute toxicities associated with cetuximab-based bioradiotherapy and platinum-based chemoradiotherapy for head and neck squamous cell carcinomas: a single-institution retrospective study in Japan","volume":"135","author":"Sakashita","year":"2015","journal-title":"Acta Otolaryngol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2016.05.008_bib13","doi-asserted-by":"crossref","first-page":"E905","DOI":"10.1002\/hed.24125","article-title":"Toxicity of concomitant cetuximab and radiotherapy with or without initial taxane-based induction chemotherapy in locally advanced head and neck cancer","volume":"38","author":"Levy","year":"2016","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.ejca.2016.05.008_bib14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0019-509X.82872","article-title":"Cetuximab with radiotherapy in patients with loco-regionally advanced squamous cell carcinoma of head and neck unsuitable or ineligible for concurrent platinum-based chemo-radiotherapy: ready for routine clinical practice?","volume":"48","author":"Agarwal","year":"2011","journal-title":"Indian J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2016.05.008_bib15","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.oraloncology.2015.04.012","article-title":"Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer","volume":"51","author":"Strom","year":"2015","journal-title":"Oral Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2016.05.008_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2008.01.012","article-title":"Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.ejca.2016.05.008_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/djn025","article-title":"Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers","volume":"100","author":"Gillison","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2016.05.008_bib18","unstructured":"Radiation Therapy Oncology Group. Radiation therapy with cisplatin or cetuximab in treating patients with oropharyngeal cancer. ClinicalTrials.gov Web site. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01302834. Published February 22, 2011. Updated 2014. [accessed 04.09.15]."},{"issue":"5s","key":"10.1016\/j.ejca.2016.05.008_bib19","article-title":"E1308: reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC)","volume":"32","author":"Cmelak","year":"2014","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916321396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916321396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:57:32Z","timestamp":1536641852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916321396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"alternative-id":["S0959804916321396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.05.008","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}